Loading…

Edwards Lifesciences Corporation chose the Mid-West of Ireland for a new plant to manufacture delivery components for transcatheter heart valve therapies. Investment is expected to be €80 million, with 600 jobs when fully operational. Initial site in Shannon Free Zone, new facility planned for completion in 2020.
“The addition of a manufacturing location in Ireland is an element of Ed”enterprise.gov.ie
Summarized from public sources; check the original articles before acting on it.